NASDAQ

Tvardi Therapeutics, Inc. (TVRD)

♥ 470 Thanks from members

Live price chart, market sentiment, and community perspectives for Tvardi Therapeutics, Inc. (NASDAQ: TVRD).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: Biotechnology / OncologyFounder: Tvardi Therapeutics Scientific FoundersLeadership: Imran Alibhai (CEO)Leadership: David Blaha (CFO)Holder: Venture Capital InvestorsHolder: Institutional Life Science FundsSTAT3 InhibitorsOncology TherapeuticsFibrosis Treatments#TVRD#Tvardi Therapeutics#Biotech Stock#STAT3 Inhibitor#Cancer Research